New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Avid Bioservices, Inc.
CDMO
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

789M

Biotechnology

Next Earning date - 05 Dec 2024

789M

Biotechnology

Next Earning date - 05 Dec 2024

12.33USD
Shape0.01 ( 0.08%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-24%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated December 3, 2024
1W -0.40 % 1M 18.96 % 3M 33.12 % 1Y 126.52 %

Key Metrics

Shape
  • Market Cap

    788.58M


  • Shares Outstanding

    63.96M


  • Share in Float

    63.21M


  • Dividende

    0


  • Earning Date

    05 Dec 2024


  • Price Target

    12.33


  • Average Volume

    1.87M


  • Beta

    1.405


  • Range

    4.07-12.48


  • Industry

    Biotechnology


  • Website

    https://www.avidbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

5.54x

P/S Ratio

13.38x

P/B Ratio

2.6

Debt/Equity

-101.3%

Net Margin

$-2.3

EPS

How CDMO compares to sector?

P/E Ratio

Relative Strength

Shape

CDMO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$164M

Shape307%

2025-Revenue

$0.29

Shape-239%

2025-EPS

$6M

Shape4329%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

KeyBanc

upgrade

Previous: Not converted

2023-03-14

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.01
vs 0.1

Q1.23

arrow
arrow

-22%

0.07
vs 0.09

Q2.23

arrow
arrow

-29%

0.05
vs 0.07

Q3.23

arrow
arrow

N/A

-0.03
vs 0.04

Q4.23

arrow
arrow

N/A

-0.12
vs -0.01

Q1.24

arrow
arrow

N/A

-0.08
vs 0.07

Q2.24

arrow
arrow

N/A

-0.07
vs 0.05

Q3.24

arrow
arrow

N/A

-0.03
vs -0.03

Q4.24

arrow
arrow

N/A

-0.12
vs -0.12

Q1.25

arrow
arrow

N/A

-0.06
vs -0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+33%

34.8M  vs 26.1M

Q1.23

arrow
arrow

+21%

38M  vs 31.5M

Q2.23

arrow
arrow

+27%

39.8M  vs 31.2M

Q3.23

arrow
arrow

+3%

37.7M  vs 36.7M

Q4.23

arrow
arrow

-27%

25.4M  vs 34.8M

Q1.24

arrow
arrow

-11%

33.8M  vs 38M

Q2.24

arrow
arrow

+8%

43M  vs 39.8M

Q3.24

arrow
arrow

+6%

40.2M  vs 37.7M

Q4.24

arrow
arrow

+33%

33.8M  vs 25.4M

Q1.25

arrow
arrow

+25%

42.3M  vs 33.8M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-1%

-0.01
vs 0.01

Q1.23

arrow
arrow

+0%

0
vs -0.01

Q2.23

arrow
arrow

0%

-0.00
vs 0

Q3.23

arrow
arrow

-1%

-0.01
vs -0.00

Q4.23

arrow
arrow

-5%

-0.05
vs -0.01

Q1.24

arrow
arrow

-3%

-0.03
vs -0.05

Q2.24

arrow
arrow

-202%

-2.02
vs -0.03

Q3.24

arrow
arrow

-9%

-0.09
vs -2.02

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

170

170
vs 180

-6%

Q1.23

arrow
arrow

173

173
vs 170

2%

Q2.23

arrow
arrow

172

172
vs 173

-1%

Q3.23

arrow
arrow

171

171
vs 172

-1%

Q4.23

arrow
arrow

178

178
vs 171

4%

Q1.24

arrow
arrow

168

168
vs 178

-6%

Q2.24

arrow
arrow

173

173
vs 168

3%

Q3.24

arrow
arrow

176

176
vs 173

2%

Earnings Growth

Latest News